How to Evaluate GenAI Tools: Considerations for Marketers
Considerations for marketers—regarding data, copyright, cost and use cases—when evaluating new GenAI tools.
Considerations for marketers—regarding data, copyright, cost and use cases—when evaluating new GenAI tools.
According to Gartner’s latest Hype Cycle, which focused on evaluating CDPs for the first time, the technology is less appealing to the marketing industry than it was a few years ago.
Five things B2B marketers can do right now to succeed in a cookieless world.
A five-step approach to strategically master programmatic advertising for B2B audiences.
Multichannel rights are an important part of digital marketing, and now is the time to make sure you have your website set up properly. Here are strategies for navigating the new landscape.
When it comes to marketing AI brands themselves, there are unique challenges to that exercise, such as navigating hype cycles, pushing the human-centric element and crafting high-tech storytelling.
When does personal cross over to creepy? Here's a look at how personalization can go right—and how it can go terribly wrong.
How marketers can confront issues like copyright, misinformation and bias while also leveraging genAI technology to improve business outcomes.
A look at the top CTV trends present at CES 2024.
Marketing and PR professionals can consider incrementality testing as a way to supplement reporting and help maximize the value of AI-based platforms, such as Meta's recently released Advantage+.
Click here to view the 2023 winners!